Karen Soares, an officer at Clover Health Investments, has filed a Form 144 to sell 19,275 shares of the company’s common stock. This transaction is significant as it follows the vesting of restricted stock units acquired on September 15, 2026. The filing reflects ongoing activity among executives in the healthcare sector, showcasing how management decisions can influence market dynamics.
Clover Health Investments, previously known as Clover Health Investments, Corp., operates under the SIC code for Hospital & Medical Service Plans. The company is incorporated in Delaware and has its business address in Jersey City, New Jersey. The firm has been actively filing various forms with the SEC, indicating a dynamic operational environment.
The recent filing indicates that Soares sold 14,673 shares on October 15, 2026, for gross proceeds of $68,669.64, and an earlier sale of 6,846 shares on September 15, 2026, for $32,723.88. The aggregate market value of the shares to be sold in the current filing is $85,581.00. The securities are being sold through Morgan Stanley Smith Barney LLC Executive Financial Services, a broker involved in the transaction.
This move may affect shareholders and potential investors in Clover Health, as executive stock sales can sometimes signal changes in confidence about the company's future performance. However, the filing does not provide further details on future actions or implications for the company.
As of now, no additional filings or actions are indicated following this transaction. The filing serves as a notice of the sale and does not specify any further developments.